D-Wave Quantum Inc. Files 8-K on Financials and Exhibits
Ticker: QBTS · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1907982
| Field | Detail |
|---|---|
| Company | D-Wave Quantum INC. (QBTS) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50, $175 million, $160 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, regulation-fd
Related Tickers: DWAVE
TL;DR
DWAVE filed an 8-K on 12/12/24 covering financials and exhibits, including common stock and warrant info.
AI Summary
D-Wave Quantum Inc. filed an 8-K on December 12, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details information related to common stock and warrants as of December 12, 2024. The company's principal executive offices are located at 2650 East Bayshore Road, Palo Alto, California.
Why It Matters
This filing provides important updates on D-Wave Quantum's financial status and corporate actions, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- D-Wave Quantum Inc. (company) — Registrant
- December 12, 2024 (date) — Date of Report
- 2650 East Bayshore Road (location) — Principal Executive Offices Address
- Palo Alto, California (location) — Principal Executive Offices City and State
FAQ
What is the purpose of this 8-K filing by D-Wave Quantum Inc.?
The purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits as of December 12, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 12, 2024.
Where are D-Wave Quantum Inc.'s principal executive offices located?
D-Wave Quantum Inc.'s principal executive offices are located at 2650 East Bayshore Road, Palo Alto, California.
What specific financial items are mentioned in relation to the filing date?
The filing mentions information related to us-gaap:CommonStockMember and us-gaap:WarrantMember as of December 12, 2024.
What is the company's state of incorporation and fiscal year end?
The company is incorporated in Delaware and its fiscal year ends on December 31.
Filing Stats: 816 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-12-12 07:08:36
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share QBTS New York Stock Exchange
- $11.50 — of common stock at an exercise price of $11.50 QBTS.WT New York Stock Exchange Indic
- $175 million — it has successfully completed sales of $175 million in gross proceeds of its common stock p
- $160 million — iscal 2024 fourth quarter with at least $160 million in cash. The funds were used, and will
Filing Documents
- qbts-20241212.htm (8-K) — 33KB
- exhibit991d-waveannouncess.htm (EX-99.1) — 7KB
- 0001907982-24-000190.txt ( ) — 206KB
- qbts-20241212.xsd (EX-101.SCH) — 2KB
- qbts-20241212_def.xml (EX-101.DEF) — 15KB
- qbts-20241212_lab.xml (EX-101.LAB) — 27KB
- qbts-20241212_pre.xml (EX-101.PRE) — 16KB
- qbts-20241212_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 12, 2024, D-Wave Quantum Inc. ("D-Wave" or the "Company") announced that it has successfully completed sales of $175 million in gross proceeds of its common stock pursuant to its previously disclosed "at-the-market" equity offering programs (the "ATM Programs"). D-Wave expects to end the current fiscal 2024 fourth quarter with at least $160 million in cash. The funds were used, and will continue to be used, for working capital and capital expenditures in support of D-Wave's ongoing technical development efforts and business operations. The Company believes this funding substantially improves the Company's financial strength, positioning D-Wave for the future and enabling it to fully execute against its product and go-to-market strategies and roadmaps. A copy of the press release is attached as Exhibit 99.1. The information in this Item 7.01 to this Current Report on Form 8-K, including Exhibit 99.1, is intended to be furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Forward-Looking Statements
Forward-Looking Statements Certain statements in this report are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this report in making an investment decision, which are based on information available to the Company on the date hereof. The Company undertakes no duty to update this information unless required by law.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits . (d) Exhibits Exhibit No. Description 99.1 Press release, dated December 12, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 12, 2024 D-Wave Quantum Inc. By: /s/ Alan Baratz Name: Alan Baratz Title: President & Chief Executive Officer